ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

FHTX Foghorn Therapeutics Inc

5.83
0.00 (0.00%)
プレマーケット
最終更新日: 18:04:13
15分遅延
名称 銘柄コード 市場 種別
Foghorn Therapeutics Inc FHTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 5.83 18:04:13
始値 安値 高値 終値 前日終値
5.83
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/2820:00GLOBEFoghorn Therapeutics to Participate in Upcoming Investor..
2024/5/2320:03EDGAR2Form 8-K - Current report
2024/5/2307:21GLOBEFoghorn Therapeutics Raises Approximately $110 Million..
2024/5/2305:05EDGAR2Form 8-K - Current report
2024/5/2105:31EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/2021:02EDGAR2Form 8-K - Current report
2024/5/0705:54EDGAR2Form 8-K - Current report
2024/5/0620:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0620:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/5/0620:03EDGAR2Form 8-K - Current report
2024/3/0721:11EDGAR2Form 8-K - Current report
2024/3/0721:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/0821:04EDGAR2Form 8-K - Current report
2024/1/2606:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2606:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2606:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2606:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2606:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1806:09EDGAR2Form 8-K - Current report
2024/1/0821:04EDGAR2Form 8-K - Current report
2024/1/0406:18EDGAR2Form 8-K - Current report
2023/11/2809:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
2023/11/2120:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
2023/11/0220:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0220:03EDGAR2Form 8-K - Current report
2023/11/0123:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
2023/9/1119:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
2023/9/0820:04EDGAR2Form 8-K - Current report
2023/9/0521:00GLOBEFoghorn Therapeutics Announces Participation in Upcoming..
2023/8/3120:04EDGAR2Form 8-K - Current report
2023/8/3120:00GLOBEFoghorn Therapeutics Announces First Patient Dosed in Phase..
2023/8/2922:00PRNUSInvaio achieves first registration for citrus greening..
2023/8/1905:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1105:08EDGAR2Form 8-K - Current report
2023/8/0820:05EDGAR2Form 8-K - Current report
2023/8/0820:00GLOBEFoghorn Therapeutics Announces Chief Medical Officer..
2023/8/0420:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0420:05EDGAR2Form 8-K - Current report
2023/8/0420:00GLOBEFoghorn Therapeutics Provides Second Quarter 2023 Financial..
2023/6/2820:00GLOBEFoghorn Therapeutics Announces Clinical Data from Phase 1..
2023/6/0521:07DJNFoghorn Therapeutics Shares Rally Premarket as FDA Lifts..

最近閲覧した銘柄

Delayed Upgrade Clock